COMP <GO>
AVIR vs PRLD // EV/EBITDA & P/E VALUATION
Atea Pharmaceuticals Inc. (NASDAQ) VS. Prelude Therapeutics Incorporated (NASDAQ) • 15-METRIC TALLY: AVIR 1
— PRLD 2
■ METRIC PARITY
LAST: $4.31 (+0.94%) • MKT CAP: $345.7M
valuation
—
LAST: $4.10 (-0.97%) • MKT CAP: $327.2M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AVIR VS. PRLD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AVIR | PRLD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -17.23% | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -60.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 73.40% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 4/9 | -1.00 | PRLD | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 32.4 | 49.1 | -16.71 | PRLD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $345.7M | $327.2M | $18.5M | AVIR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AVIR REV | PRLD REV | AVIR GROSS % | PRLD GROSS % | AVIR FCF | PRLD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $12.1M | — | — | -$132.0M | -$56.4M |
| FY 2024 | $0 | $7.0M | — | — | -$135.5M | -$103.7M |
| FY 2023 | $0 | $0 | — | — | -$85.4M | -$107.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AVIR // BETA —
PRLD // BETA —